The company maker(s) will either be Lani alone or with HRV not Relenza. And that is what i think Hunter Hall know or came across to me in the video. Any royalties going forward from Relenza is the bonus. They HH acknowledge whilst not going into their reasoning and re-hashing the whole GSK marketing issues that Relenza has only become popular and is a pandemic product / Govt stockpiling product now?
cheers
BTA Price at posting:
$1.28 Sentiment: LT Buy Disclosure: Held
